Treatments Men Discuss With Licensed Providers

FDA-approved commercial testosterone cypionate products exist for labeled hypogonadism when prescribed by a licensed clinician. Depending on clinical and pharmacy factors, some patients may receive a commercial FDA-approved finished drug and others may receive a compounded preparation from a licensed 503A/503B compounding pharmacy; compounded medications are not FDA-approved finished drugs. Dosing and monitoring (including hematocrit and fertility counseling) belong with a licensed clinician.

A compounded topical testosterone option for men who prefer a needle-free route. Compounded creams are prepared by a licensed 503A/503B compounding pharmacy and are not FDA-approved finished drugs. Application site, dose and lab monitoring are set only by your licensed clinician.

An oral medication discussed for men with clinically documented low testosterone who want to keep their own testosterone production and fertility goals in mind. Enclomiphene is not FDA-approved for any indication; whether it fits is a decision for a licensed clinician.

An aromatase inhibitor that is FDA-approved for certain breast cancers; use in men to manage estradiol is off-label. Considered only when labs and symptoms support it, under a licensed clinician.

FDA-approved hCG products are labeled for certain types of male hypogonadism. Using hCG alongside TRT to help maintain testicular function is off-label and does not guarantee fertility. Fertility goals should be discussed with a licensed clinician.

A small-amount semaglutide preparation held under the tongue until it dissolves, for men who want to ease in slowly or avoid needles. Clinics call it a microdose, but that is not an FDA-defined strength. How much drug gets absorbed this way is poorly studied, and the major weight-loss trials used injections, not this route.

Semaglutide at a standard compounded strength, taken under the tongue instead of by injection. For many men the appeal is simple: no needles. The trade-off is uncertainty, because solid data comparing under-the-tongue absorption with a subcutaneous shot are scarce. Your clinician can weigh that gap against the injectable options and your metabolic labs.

A shot that pairs semaglutide below usual starting strengths with vitamin B12 in one vial. It is sometimes chosen by men who want a gentler ramp-up because GI side effects worry them. No solid studies back this specific pairing, and a lower dose may also mean less effect. If B12 matters to you, especially with metformin use, it can be checked and treated on its own.

Lower-strength semaglutide mixed in the same vial with glycine, an amino acid. Some prescribers include glycine on the theory that it helps metabolism, but that idea has not been tested in this combination. For men, the bigger questions are usually protecting lean mass and tracking labs as weight changes. Think limited evidence and a slower start, not a shortcut.

Standard-strength compounded semaglutide with vitamin B12 in the vial. The usual rationale is energy while eating less, but there is no good evidence that the B12 adds anything to weight loss. Men whose weight is pushing up A1C, lipids or blood pressure may discuss it with a clinician, and B12 status can be tested separately.

Standard-strength compounded semaglutide with glycine, an amino acid some compounders add for possible stability or metabolic reasons. Research on this exact mix is thin. Because some of the weight lost on GLP-1 medicines in trials was lean mass, men are generally advised to pair treatment with resistance training and enough protein, and to keep their labs current.

Tirzepatide in a small, clinic-defined amount that dissolves under the tongue. The idea is a slow, needle-free entry point for men who are wary of side effects. There is no FDA-approved oral or sublingual tirzepatide, and absorption and effect at this scale have not been well studied. Treat it as an experimental route, not a proven one.

A needle-free compounded tirzepatide taken under the tongue rather than injected. Men who dislike shots often ask about it first. The catch: the large tirzepatide trials studied injections, and we lack good data on how much drug reaches the bloodstream this way. If you are also on TRT, keep your scheduled TRT labs on track.

Compounded tirzepatide at a lower-than-usual strength, combined with vitamin B12 in a single vial. The rationale is a slower ramp for men sensitive to GI effects. Proof for this particular blend is thin, and the maker of brand-name tirzepatide has publicly raised impurity concerns about tirzepatide mixed with B12. B12 can always be given separately.

A reduced-strength tirzepatide injection with glycine mixed in. Glycine gets promoted for metabolic or sleep support, yet no strong research shows it adds anything when combined with tirzepatide. A start-low approach may suit men worried about nausea, while the real work stays the same: lifting, protein and regular labs.

Compounded tirzepatide at standard strength with vitamin B12 in the vial. B12 is pitched as an energy aid during a calorie deficit, but proof that it improves results with tirzepatide is lacking, and same-vial mixing has drawn impurity questions. For men with stubborn belly fat and worsening metabolic labs, a clinician can judge whether B12 belongs in the vial at all.

Standard-strength compounded tirzepatide paired with glycine, an amino acid some pharmacies add for possible metabolic support. Data on this exact combination are sparse. Weight lost on GLP-1-based drugs can include muscle as well as fat, so training and protein matter. In men with obesity, losing weight is often associated with higher testosterone, though that is not guaranteed.

A lab-made version of the hormone that signals the pituitary to release growth hormone (a GHRH analogue). Men usually ask about it for sleep, recovery and body composition. Those benefits are possible, not proven, and the evidence trails well behind FDA-approved growth hormone treatments. It is on the WADA prohibited list, which matters if you compete in tested sport.

Your body makes glutathione, a key antioxidant, on its own. Injected glutathione is marketed for oxidative stress and cell health, and some men pair it with hard training or recovery goals. Studies of injections in healthy people are inconsistent, so treat any benefit as uncertain rather than expected.

A synthetic peptide modeled on a fragment of a protein found in stomach fluid. It draws interest from lifters and athletes for tendon, ligament and gut recovery, but nearly all of the evidence comes from animal studies. Human trials are scarce, so it remains a research-stage compound, and WADA bans it for tested athletes.

A copper-binding peptide researched mainly for skin repair and wound healing, with antioxidant and tissue-remodeling effects seen in lab work. Injecting it for whole-body wellness or recovery is far less supported than applying it to skin. Men curious about it should know the systemic case is the weaker one.

The copper peptide GHK-Cu in a compounded cream applied directly to skin. Men usually ask about it for skin texture and firmness, and it has been studied for wound healing. The research behind topical use is stronger than for injections, but individual results vary and the compounded cream is not an FDA-approved product.

A peptide encoded in mitochondrial DNA, studied for how it may influence metabolism, insulin sensitivity and exercise capacity. That makes it interesting to men focused on conditioning and metabolic health. Most findings come from animal and early human work, so real-world benefit is unknown.

A GHRH analogue whose FDA-approved use is reducing excess abdominal fat in people with HIV-associated lipodystrophy. Because that indication targets belly fat, men sometimes ask about it for visceral fat. Compounded tesamorelin used for general body composition or anti-aging is not FDA-approved for those purposes, and it is prohibited in tested sport.

A four-amino-acid synthetic peptide studied for possible effects on telomeres and aging. It shows up often in longevity circles, but almost all of the data come from animal and cell studies, and human evidence is very thin. For men focused on healthy aging, proven basics like labs, training and sleep still come first.

SS-31 (elamipretide) is a peptide that targets mitochondria. An elamipretide product received FDA accelerated approval in 2025 only for Barth syndrome, a rare inherited disease; compounded SS-31 is not that product. Men ask about it for heart health, endurance and aging, but human data for those uses are limited and early-stage.

A peptide first isolated from the thymus and researched for its effects on immune function. Some countries have used it for hepatitis and immune support, but it is not FDA-approved in the US, and evidence for everyday wellness or immune resilience during heavy training in healthy men is limited.

Two neuropeptides developed in Russia and studied there for focus and anxiety-related effects. Men drawn to them usually want sharper concentration or a calmer stress response. Rigorous Western peer-reviewed human trials are very limited, so any cognitive benefit should be considered unproven.

Pairs CJC-1295, a GHRH analogue, with ipamorelin, a growth hormone secretagogue, to prompt the body's own growth hormone release. It is popular with men interested in sleep, recovery and lean mass, but the evidence is thinner than for approved growth hormone therapies. Both are prohibited under WADA rules, and the stack does not replace TRT or lab-guided care.

BPC-157 combined with TB-500, a fragment related to thymosin beta-4. Both have been studied for tissue repair and recovery in animals, which is why the stack is popular with men managing training injuries. Human data are limited for each peptide, no clinical trial has tested the pair together, and both are banned in tested sport.

Three peptides in one: BPC-157, TB-500 and GHK-Cu, aimed at tissue repair, recovery and skin. Men who train hard sometimes ask about it for recovery and skin quality at once. Each ingredient has limited human data, and no clinical trial has studied the three together, so the combination's effects are unknown.

The Glow Stack plus KPV, a small melanocortin-derived peptide researched for anti-inflammatory activity. It comes up with men who want a broader recovery blend. No clinical trial data exist for this four-peptide combination, and adding ingredients does not add proof. Ask what each component is meant to do before considering it.

Bremelanotide, a melanocortin receptor agonist studied in sexual dysfunction. The FDA-approved bremelanotide product is approved only for low sexual desire in premenopausal women, so use in men is off-label, and compounded versions are not FDA-approved. It does not replace an erectile dysfunction workup, since ED can be an early sign of heart or hormone problems.

NAD+ is a coenzyme your cells rely on to turn food into usable energy, and levels are thought to fall with age. Injectable NAD+ is offered to men for energy, mental clarity and cellular repair, but large clinical trials are lacking. Consider it an exploratory option rather than a proven performance aid.

A lipotropic shot that blends B vitamins with compounds such as methionine, inositol and choline, marketed for fat metabolism and energy. Men sometimes use it alongside a cut or a GLP-1 plan. There is little evidence it produces meaningful fat loss beyond diet and exercise, so it is an add-on to the basics, not a substitute.

A topical serum built on minoxidil, an ingredient with FDA-approved use for androgenetic alopecia, the common male-pattern hair loss. Compounded strengths and blends differ from approved products and are not FDA-approved. Thinning hair sometimes comes up for men on TRT, since testosterone converts to DHT; your clinician can walk through options.

Naltrexone has FDA approval at standard doses for opioid and alcohol use disorder. Prescribing it at much lower doses for immune modulation, pain or inflammation is off-label and not FDA-approved at those strengths. Some men ask about it for joint aches or training-related inflammation; the research is growing but still not conclusive.

Hormone replacement therapy, GLP-1 and wellness care for women is handled by Dominia Health, our dedicated women's telehealth brand operated by Clarity Health LLC.